| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles. | Int J Radiat Oncol Biol Phys | 2004 | 1.12 |
| 2 | Synthesis, in vitro, and in vivo characterization of an integrin alpha(v)beta(3)-targeted molecular probe for optical imaging of tumor. | Bioorg Med Chem | 2005 | 1.11 |
| 3 | Use of antibody as carrier of oligomers of peptidomimetic alphavbeta3 antagonist to target tumor-induced neovasculature. | Bioconjug Chem | 2007 | 0.86 |
| 4 | Radiolabeled high affinity peptidomimetic antagonist selectively targets alpha(v)beta(3) receptor-positive tumor in mice. | Nucl Med Biol | 2007 | 0.83 |
| 5 | Tc-labeling of Peptidomimetic Antagonist to Selectively Target alpha(v)beta(3) Receptor-Positive Tumor: Comparison of PDA and EDDA as co-Ligands. | Curr Radiopharm | 2010 | 0.78 |